# Anagenex

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/anagenex

- Industry: Biotechnology
- Headquarters: San Francisco, US
- Website: www.anagenex.com
- Total disclosed funding: $37M
- Latest round: Series A (Jun 8, 2022)
- Investors on record: 6

## About

Founded in 2019, and based in California, US, Anagenex, Inc. operates as a biotechnology company that focuses on the discovery of small molecule medicines through biochemical experiments and machine learning.

## Funding rounds

- Series A, Jun 8, 2022, $30M — Menlo Ventures, Khosla Ventures, Lux Capital, Obvious, Air Street Capital, Catalio Capital Management
- Seed, Jun 1, 2020, $7.2M — Menlo Ventures, Khosla Ventures, Lux Capital, Obvious, Air Street Capital

## Investors

- Menlo Ventures (https://capitalatlas.ai/funds/menlo-ventures) — Seed, Series A
- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Seed, Series A
- Lux Capital (https://capitalatlas.ai/funds/lux-capital) — Seed, Series A
- Obvious (https://capitalatlas.ai/funds/obvious) — Seed, Series A
- Air Street Capital (https://capitalatlas.ai/funds/air-street-capital) — Seed, Series A
- Catalio Capital Management (https://capitalatlas.ai/funds/catalio-capital-management) — Series A